Corvus Pharmaceuticals, Inc. (CRVS) insider trading
Over the last 12 months, 2 insiders bought $334K and 0 insiders sold $0 of Corvus Pharmaceuticals, Inc. stock on the open market, according to SEC Form 4 filings.
Latest insider buys and sells
- Jun 11, 2026: Moore David Scott bought 21,700 shares ($250K)
- May 18, 2026: Miller Richard A Md bought 6,932 shares ($83.5K)
- Jun 27, 2025: Thompson Peter A. sold 1,176,332 shares ($4.89M)
- Jun 27, 2025: Orbimed Advisors Llc sold 1,176,332 shares ($4.89M)